
PBM for AMD now in NZ
Photobiomodulation (or LLLT) for AMD is now available in New Zealand

Photobiomodulation (or LLLT) for AMD is now available in New Zealand

Following the release of three-month interim findings1, the Ocular Surface Laboratory (OSL) team has now completed the full six-month analysis of a trial comparing handheld thermal pulsation therapy w

A new study has found therapeutic potential in synthetic collagen mimetic peptides (CMPs) in treating ophthalmic disease, including myopia. Published in Pharmaceuticals, the study results indicate t

A new imaging approach, Fun-IVCM, is able to track the presence of inflammation in dry eye disease

Since dry eye often needs long-term and regular treatment with eye drops, compliance is important to achieve favourable therapeutic outcomes. Difficulty in squeezing eye drop containers has been reported as one of the major barriers for eye drop compliance1,2.

Ocula Group has bought Haydon Optometrists in Takapuna on Auckland’s North Shore. It is the group’s second landing in Tāmaki Makaurau, following last year’s acquisition of Remuera’s Gates Eyewear. D

Ophthalmology New Zealand (ONZ) has held its first Specialist International Medical Graduate (SIMG) webinar to explore ways to better support overseas ophthalmologists and reduce reliance on them.

Specsavers is extending its eyecare services, introducing intense pulsed light (IPL) and low-level light therapy (LLLT) treatments for dry eye disease (DED) to four New Zealand stores: Te Rapa, Hornby

Young people are not immune to the effects of dry eye disease (DED)1. The average university student spends upwards of eight hours each day staring at screens while often running low on sleep. Therefore, it is no surprise that we are seeing a high number of students with DED2,3. But are these lifest

Prompt treatment for primary Sjögren’s disease in patients who develop cerebral infarction (CI) helps promote neurological recovery and reduce the risk of stroke recurrence, a new study found. The r

A Swedish study has shown that dermatochalasis surgery (blepharoplasty) of the upper eyelid improved headache-related quality of life and may not be as worrisome for dry eye as previously thought. A

Australian and Swiss researchers found “a significant proportion” of choroidal neovascular membrane (CNV) lesions were inactivated and treatment intervals extended in patients with neovascular age-rel